These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36222553)

  • 41. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
    Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy.
    Rosen O; Massenkeil G; Hiepe F; Pest S; Hauptmann S; Radtke H; Burmester G; Thiel A; Radbruch A; Heymer B; Arnold R
    Bone Marrow Transplant; 2001 Mar; 27(6):657-8. PubMed ID: 11319598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis.
    Kuwana M; Kaburaki J; Mimori T; Kawakami Y; Tojo T
    Arthritis Rheum; 2000 May; 43(5):1074-84. PubMed ID: 10817562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?
    van Rhijn-Brouwer FCC; Spierings J; van Laar JM
    Immunol Lett; 2018 Mar; 195():88-96. PubMed ID: 29155233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
    Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
    Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
    Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
    Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
    Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
    J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells.
    Tsukamoto H; Nagafuji K; Horiuchi T; Mitoma H; Niiro H; Arinobu Y; Inoue Y; To K; Miyamoto T; Iwasaki H; Teshima T; Harada M; Akashi K
    Rheumatology (Oxford); 2011 May; 50(5):944-52. PubMed ID: 21172925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
    Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
    J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
    Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-RNA polymerase antibodies in systemic sclerosis (SSc): association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II.
    Harvey GR; Rands AL; McHugh NJ
    Clin Exp Immunol; 1996 Sep; 105(3):468-74. PubMed ID: 8809136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
    Mahler M; Silverman ED; Schulte-Pelkum J; Fritzler MJ
    Autoimmun Rev; 2010 Sep; 9(11):756-60. PubMed ID: 20601198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
    Miyake M; Matsushita T; Takehara K; Hamaguchi Y
    Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
    Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
    Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
    Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
    Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of anti-AT1R reactivity in ELISA post-adsorption - False reactivity or interference in the assay?
    Xu Q; Johnson KP; Hardiman M; Helmick D; Zeevi A
    Hum Immunol; 2023 Apr; 84(4):286-289. PubMed ID: 36764862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice.
    Hu PQ; Hurwitz AA; Oppenheim JJ
    J Rheumatol; 2007 Nov; 34(11):2243-52. PubMed ID: 17937466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.